BEAM
Price
$17.86
Change
-$0.44 (-2.40%)
Updated
Aug 7, 04:59 PM (EDT)
Capitalization
1.81B
95 days until earnings call
CRBU
Price
$1.80
Change
-$0.08 (-4.26%)
Updated
Aug 7, 04:59 PM (EDT)
Capitalization
174.85M
5 days until earnings call
Interact to see
Advertisement

BEAM vs CRBU

Header iconBEAM vs CRBU Comparison
Open Charts BEAM vs CRBUBanner chart's image
Beam Therapeutics
Price$17.86
Change-$0.44 (-2.40%)
Volume$21.92K
Capitalization1.81B
Caribou Biosciences
Price$1.80
Change-$0.08 (-4.26%)
Volume$13.23K
Capitalization174.85M
BEAM vs CRBU Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. CRBU commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and CRBU is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (BEAM: $17.86 vs. CRBU: $1.88)
Brand notoriety: BEAM and CRBU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 80% vs. CRBU: 79%
Market capitalization -- BEAM: $1.81B vs. CRBU: $174.85M
BEAM [@Biotechnology] is valued at $1.81B. CRBU’s [@Biotechnology] market capitalization is $174.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileCRBU’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • CRBU’s FA Score: 1 green, 4 red.
According to our system of comparison, CRBU is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while CRBU’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 6 bearish.
  • CRBU’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CRBU is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -9.39% price change this week, while CRBU (@Biotechnology) price change was -8.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.15%. For the same industry, the average monthly price growth was +8.44%, and the average quarterly price growth was +12.41%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

CRBU is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+1.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.81B) has a higher market cap than CRBU($175M). CRBU YTD gains are higher at: 18.239 vs. BEAM (-27.984). CRBU has higher annual earnings (EBITDA): -159.14M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. CRBU (208M). CRBU has less debt than BEAM: CRBU (26.2M) vs BEAM (158M). BEAM has higher revenues than CRBU: BEAM (63.6M) vs CRBU (9.92M).
BEAMCRBUBEAM / CRBU
Capitalization1.81B175M1,033%
EBITDA-399.03M-159.14M251%
Gain YTD-27.98418.239-153%
P/E RatioN/AN/A-
Revenue63.6M9.92M641%
Total Cash1.22B208M587%
Total Debt158M26.2M603%
TECHNICAL ANALYSIS
Technical Analysis
BEAMCRBU
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 16 days ago
79%
Bullish Trend 16 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGHYX39.57N/A
N/A
Hartford Healthcare Y
PRVRX12.86N/A
N/A
PGIM Quant Solutions Large-Cap Val R
TSNIX57.75N/A
N/A
T. Rowe Price Science & Tech I
AVUGX8.16N/A
N/A
American Century Value R5
LQFLX14.43N/A
N/A
Lord Abbett Focused Large Cap Value R3

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with CRSP. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-7.84%
CRSP - CRBU
60%
Loosely correlated
+1.35%
BEAM - CRBU
56%
Loosely correlated
-2.14%
RXRX - CRBU
54%
Loosely correlated
-0.90%
FATE - CRBU
53%
Loosely correlated
-3.70%
NTLA - CRBU
53%
Loosely correlated
-1.81%
More